252 related articles for article (PubMed ID: 37351176)
1. Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation.
Xiong M; Chen H; Fan Y; Jin M; Yang D; Chen Y; Zhang Y; Petersen RB; Su H; Peng A; Wang C; Zheng L; Huang K
Theranostics; 2023; 13(10):3387-3401. PubMed ID: 37351176
[No Abstract] [Full Text] [Related]
2. Effect of Fc-Elabela-21 on renal ischemia/reperfusion injury in mice: Mediation of anti-apoptotic effect via Akt phosphorylation.
Xu F; Wu M; Lu X; Zhang H; Shi L; Xi Y; Zhou H; Wang J; Miao L; Gong DW; Cui W
Peptides; 2022 Jan; 147():170682. PubMed ID: 34742787
[TBL] [Abstract][Full Text] [Related]
3. ELABELA and an ELABELA Fragment Protect against AKI.
Chen H; Wang L; Wang W; Cheng C; Zhang Y; Zhou Y; Wang C; Miao X; Wang J; Wang C; Li J; Zheng L; Huang K
J Am Soc Nephrol; 2017 Sep; 28(9):2694-2707. PubMed ID: 28583915
[TBL] [Abstract][Full Text] [Related]
4. Fc-Elabela fusion protein attenuates lipopolysaccharide-induced kidney injury in mice.
Xu F; Zhou H; Wu M; Zhang H; Zhang Y; Zhao Q; Brown R; Gong DW; Miao L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32808659
[TBL] [Abstract][Full Text] [Related]
5. Arginase 2 is a mediator of ischemia-reperfusion injury in the kidney through regulation of nitrosative stress.
Hara M; Torisu K; Tomita K; Kawai Y; Tsuruya K; Nakano T; Kitazono T
Kidney Int; 2020 Sep; 98(3):673-685. PubMed ID: 32739205
[TBL] [Abstract][Full Text] [Related]
6. Elabela-APJ axis attenuates cerebral ischemia/reperfusion injury by inhibiting neuronal ferroptosis.
Xu P; Kong L; Tao C; Zhu Y; Cheng J; Li W; Shen N; Li R; Zhang C; Wang L; Zhang Y; Wang G; Liu X; Sun W; Hu W
Free Radic Biol Med; 2023 Feb; 196():171-186. PubMed ID: 36681202
[TBL] [Abstract][Full Text] [Related]
7. PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury.
Wang C; Xiong M; Yang C; Yang D; Zheng J; Fan Y; Wang S; Gai Y; Lan X; Chen H; Zheng L; Huang K
J Med Chem; 2020 Dec; 63(24):16028-16042. PubMed ID: 33290073
[TBL] [Abstract][Full Text] [Related]
8. Role of protease-activated receptor 4 in mouse models of acute and chronic kidney injury.
Erreger K; Cao S; Pan Y; Jiang M; Zhang MZ; Harris RC; Hamm HE
Am J Physiol Renal Physiol; 2024 Feb; 326(2):F219-F226. PubMed ID: 38031732
[TBL] [Abstract][Full Text] [Related]
9. VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression.
Chen J; Lu H; Wang X; Yang J; Luo J; Wang L; Yi X; He Y; Chen K
FASEB J; 2022 Sep; 36(9):e22472. PubMed ID: 35959877
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
[TBL] [Abstract][Full Text] [Related]
11. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
[TBL] [Abstract][Full Text] [Related]
12. A two-stage bilateral ischemia-reperfusion injury-induced AKI to CKD transition model in mice.
Zhang J; Wang X; Wei J; Wang L; Jiang S; Xu L; Qu L; Yang K; Fu L; Buggs J; Cheng F; Liu R
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F304-F311. PubMed ID: 32567350
[TBL] [Abstract][Full Text] [Related]
13. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.
Chen Z; Wu C; Liu Y; Li H; Zhu Y; Huang C; Lin H; Qiao Q; Huang M; Zhu Q; Wang L
Cell Death Dis; 2020 Aug; 11(8):698. PubMed ID: 32829380
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 15-PGDH prevents ischemic renal injury by the PGE
Kim HJ; Kim SH; Kim M; Baik H; Park SJ; Kang MS; Kim DH; Kim BW; Markowitz SD; Bae KB
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1054-F1066. PubMed ID: 33135478
[TBL] [Abstract][Full Text] [Related]
16. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
Gao X; Han L; Yao X; Ma L
Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
[TBL] [Abstract][Full Text] [Related]
17. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
[TBL] [Abstract][Full Text] [Related]
18. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
19. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.
Chen Y; Lin L; Tao X; Song Y; Cui J; Wan J
BMC Nephrol; 2019 Mar; 20(1):106. PubMed ID: 30922260
[TBL] [Abstract][Full Text] [Related]
20. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
